Growth Metrics

Merck (MRK) Receivables (2016 - 2025)

Merck (MRK) has disclosed Receivables for 17 consecutive years, with $11.8 billion as the latest value for Q4 2025.

  • Quarterly Receivables rose 14.57% to $11.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.8 billion through Dec 2025, up 14.57% year-over-year, with the annual reading at $11.8 billion for FY2025, 14.57% up from the prior year.
  • Receivables for Q4 2025 was $11.8 billion at Merck, down from $12.1 billion in the prior quarter.
  • The five-year high for Receivables was $12.1 billion in Q3 2025, with the low at $51.0 million in Q2 2023.
  • Average Receivables over 5 years is $7.4 billion, with a median of $10.3 billion recorded in 2023.
  • The sharpest move saw Receivables crashed 98.13% in 2021, then soared 22727.45% in 2024.
  • Over 5 years, Receivables stood at $1.2 billion in 2021, then soared by 706.56% to $10.0 billion in 2022, then rose by 3.9% to $10.3 billion in 2023, then dropped by 0.69% to $10.3 billion in 2024, then rose by 14.57% to $11.8 billion in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $11.8 billion, $12.1 billion, and $11.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.